Split-virion—versus subunit—inactivated influenza vaccines provided greater clinical effectiveness among adults ≥50 years of age who sought care for acute respiratory illness during three separate flu seasons.
IDWeek 2014: Vaccines
High-dose—versus standard-dose—inactivated influenza vaccine resulted in a significantly shorter duration of laboratory-confirmed influenza respiratory illness in older adults.
Want to read more?
Please login or register first to view this content.